Literature DB >> 8435473

The role of cell adhesion molecules in cancer invasion and metastasis.

J Behrens1.   

Abstract

Invasion and metastasis of tumor cells is the primary cause for the fatal outcome of cancer diseases. A striking feature of metastatic cells is the considerable flexibility in their adhesive interactions with other cells or components of the extracellular matrix. This review will describe the involvement of specific cell adhesion receptors, extracellular matrix molecules, and cell dissociating cytokines in the metastatic cascade. We will particularly focus on disturbance of intercellular adhesion as a prerequisite for the release of invasive cells from carcinomas. We suggest that cell dissociation in these tumors is accomplished by loss of function or expression of the epithelial cell adhesion molecule E-cadherin, and through the activity of cell motility factors, like scatter factor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435473     DOI: 10.1007/bf01833258

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  53 in total

1.  Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein.

Authors:  A Raz; G Pazerini; P Carmi
Journal:  Cancer Res       Date:  1989-07-01       Impact factor: 12.701

2.  Changes in integrin receptors on oncogenically transformed cells.

Authors:  L C Plantefaber; R O Hynes
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

3.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

4.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.

Authors:  J H Schipper; U H Frixen; J Behrens; A Unger; K Jahnke; W Birchmeier
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

Review 5.  Integrins.

Authors:  E Ruoslahti
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

6.  Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells.

Authors:  F G Giancotti; E Ruoslahti
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

7.  Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice.

Authors:  M M Mareel; J Behrens; W Birchmeier; G K De Bruyne; K Vleminckx; A Hoogewijs; W C Fiers; F M Van Roy
Journal:  Int J Cancer       Date:  1991-04-01       Impact factor: 7.396

8.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

9.  Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA.

Authors:  A Nagafuchi; Y Shirayoshi; K Okazaki; K Yasuda; M Takeichi
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

10.  Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

Authors:  L Naldini; K M Weidner; E Vigna; G Gaudino; A Bardelli; C Ponzetto; R P Narsimhan; G Hartmann; R Zarnegar; G K Michalopoulos
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  49 in total

1.  T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta-catenin.

Authors:  A I Barth; D B Stewart; W J Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Cadherins, steroids and cancer.

Authors:  O W Blaschuk; S B Munro; R Farookhi
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

3.  Establishment and characterisation of two cell lines derived from a primary adenocarcinoma of the duodenum.

Authors:  M Golding; G W Stamp; T Oates; E N Lalani
Journal:  Clin Mol Pathol       Date:  1996-02

Review 4.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

5.  LI-cadherin: a marker of gastric metaplasia and neoplasia.

Authors:  C Grötzinger; J Kneifel; D Patschan; N Schnoy; I Anagnostopoulos; S Faiss; R Tauber; B Wiedenmann; R Gessner
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

6.  Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin.

Authors:  R Bergan; E Kyle; P Nguyen; J Trepel; C Ingui; L Neckers
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

7.  The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma.

Authors:  Teresa M DesRochers; Yulia Shamis; Addy Alt-Holland; Yasusei Kudo; Takashi Takata; Guangwen Wang; Laurie Jackson-Grusby; Jonathan A Garlick
Journal:  Epigenetics       Date:  2012-01-01       Impact factor: 4.528

8.  Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation.

Authors:  Kiyomi O Toyooka; Shinichi Toyooka; Anirban Maitra; Qinghua Feng; Nancy C Kiviat; Alice Smith; John D Minna; Raheela Ashfaq; Adi F Gazdar
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Estradiol regulates E-cadherin mRNA levels in the surface epithelium of the mouse ovary.

Authors:  C D MacCalman; R Farookhi; O W Blaschuk
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

10.  Pin1 promotes transforming growth factor-beta-induced migration and invasion.

Authors:  Isao Matsuura; Keng-Nan Chiang; Chen-Yu Lai; Dongming He; Guannan Wang; Romila Ramkumar; Takafumi Uchida; Akihide Ryo; Kunping Lu; Fang Liu
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.